Dr. Agarwal: LogicVision is a pioneer in the emerging Embedded Test Technology and the largest provider of commercial intellectual property and software for embedded tests in the semiconductor industry. Our business is to modify the DNA of a chip so that it can perform self- testing and self-diagnosis throughout its life cycle. With LogicVision technology, semiconductor companies expect to save hundreds of millions of dollars in capital expenses, achieve better time to market and realize lower manufacturing costs. More than 100 companies worldwide, from fabless startups to prominent blue chip companies including Agere Systems, Broadcom, Cisco, LSI Logic, National Semiconductor, Sony and Sun Microsystems have used our products.
TWST: Could you explain your product in more detail?
Dr. Agarwal: Every silicon chip goes through several development and
manufacturing phases. The first phase is when a chip is being designed
and developed. The next phase is when a prototype chip is manufactured
and goes through a debug process to ensure that the first silicon is
fully functioning. After diagnosed as fully functioning, the next phase
is high volume production. Once produced, the chips are installed into
various electronic systems. LogicVision's technology provides propriety
technologies at the design for a semiconductor chip to test itself.
Therefore, when a first silicon or volume production chip comes back,
instead of using very sophisticated and expensive testers and
corresponding test programs, a customer would actually use testing
capabilities that are directly built inside the chip using our Embedded
Test technology with minimum requirements from outside. LogicVision's
embedded test technology enables manufacturers to reduce the cost of
test significantly. It also reduces the time that is required to debug
silicon. Furthermore, it increases the quality of test because the chips
are being tested at-speed.
Tickers included in this excerpt: LGYN
For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.